FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4239223689> ?p ?o ?g. }

• W4239223689 abstract "Background Migraine is a highly disabling condition for the individual and also has wide‐reaching implications for society, healthcare services, and the economy. Sumatriptan is an abortive medication for migraine attacks, belonging to the triptan family. Intranasal administration may be preferable to oral for individuals experiencing nausea and/or vomiting, although it is primarily absorbed in the gut, not the nasal mucosa. Objectives To determine the efficacy and tolerability of intranasal sumatriptan compared to placebo and other active interventions in the treatment of acute migraine attacks in adults. Search methods We searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, online databases, and reference lists for studies through 13 October 2011. Selection criteria We included randomised, double‐blind, placebo‐ and/or active‐controlled studies using intranasal sumatriptan to treat a migraine headache episode, with at least 10 participants per treatment arm. Data collection and analysis Two review authors independently assessed trial quality and extracted data. We used numbers of participants achieving each outcome to calculate relative risk (or 'risk ratio') and numbers needed to treat to benefit (NNT) or harm (NNH) compared to placebo or a different active treatment. Main results Twelve studies (4755 participants) compared intranasal sumatriptan with placebo or an active comparator. Most of the data were for the 10 mg and 20 mg doses. Sumatriptan surpassed placebo for all efficacy outcomes. For sumatriptan 10 mg versus placebo the NNTs were 7.3, 7.4, and 5.5 for pain‐free at two hours, and headache relief at one and two hours, respectively. For sumatriptan 20 mg versus placebo the NNTs were 4.7, 4.9, and 3.5, respectively, for the same outcomes. The 20 mg dose was significantly better than the 10 mg dose for each of these three primary efficacy outcomes. Relief of headache‐associated symptoms, including nausea, photophobia, and phonophobia, was greater with sumatriptan than with placebo, and use of rescue medication was lower with sumatriptan than placebo. For the most part, adverse events were transient and mild and were more common with sumatriptan than placebo. Direct comparison of sumatriptan with active treatments was limited to two studies, one comparing sumatriptan 20 mg and dihydroergotamine (DHE) 1 mg, and one comparing sumatriptan 20 mg with rizatriptan 10 mg. Authors' conclusions Intranasal sumatriptan is effective as an abortive treatment for acute migraine attacks, relieving pain, nausea, photophobia, phonophobia, and functional disability, but is associated with increased adverse events compared with placebo." @default.
• W4239223689 created "2022-05-12" @default.
• W4239223689 creator A5002560235 @default.
• W4239223689 creator A5029049881 @default.
• W4239223689 creator A5077191679 @default.
• W4239223689 date "2012-02-15" @default.
• W4239223689 modified "2023-09-26" @default.
• W4239223689 title "Sumatriptan (intranasal route of administration) for acute migraine attacks in adults" @default.
• W4239223689 cites W1480729244 @default.
• W4239223689 cites W1489220976 @default.
• W4239223689 cites W1610497957 @default.
• W4239223689 cites W1977521225 @default.
• W4239223689 cites W1982886878 @default.
• W4239223689 cites W1986215651 @default.
• W4239223689 cites W1990151540 @default.
• W4239223689 cites W1997338356 @default.
• W4239223689 cites W1999193930 @default.
• W4239223689 cites W2017344242 @default.
• W4239223689 cites W2019660771 @default.
• W4239223689 cites W2022676424 @default.
• W4239223689 cites W2025168050 @default.
• W4239223689 cites W2027261838 @default.
• W4239223689 cites W2038633449 @default.
• W4239223689 cites W2038693293 @default.
• W4239223689 cites W2039720823 @default.
• W4239223689 cites W2047455969 @default.
• W4239223689 cites W2047700866 @default.
• W4239223689 cites W2058055588 @default.
• W4239223689 cites W2059981326 @default.
• W4239223689 cites W2061569437 @default.
• W4239223689 cites W2061884768 @default.
• W4239223689 cites W2062818994 @default.
• W4239223689 cites W2067656815 @default.
• W4239223689 cites W2074627216 @default.
• W4239223689 cites W2084937412 @default.
• W4239223689 cites W2085587616 @default.
• W4239223689 cites W2085826886 @default.
• W4239223689 cites W2087734088 @default.
• W4239223689 cites W2092233783 @default.
• W4239223689 cites W2092890771 @default.
• W4239223689 cites W2111149452 @default.
• W4239223689 cites W2114413295 @default.
• W4239223689 cites W2116446898 @default.
• W4239223689 cites W2119011129 @default.
• W4239223689 cites W2121589750 @default.
• W4239223689 cites W2132805893 @default.
• W4239223689 cites W2149133494 @default.
• W4239223689 cites W2170860462 @default.
• W4239223689 cites W2171227218 @default.
• W4239223689 cites W2244474145 @default.
• W4239223689 cites W2415631411 @default.
• W4239223689 cites W2510856430 @default.
• W4239223689 cites W32584114 @default.
• W4239223689 cites W4211171127 @default.
• W4239223689 cites W4239223689 @default.
• W4239223689 cites W4245178225 @default.
• W4239223689 cites W4247292047 @default.
• W4239223689 cites W4298184796 @default.
• W4239223689 cites W2595437246 @default.
• W4239223689 doi "https://doi.org/10.1002/14651858.cd009663" @default.
• W4239223689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22336867" @default.
• W4239223689 hasPublicationYear "2012" @default.
• W4239223689 type Work @default.
• W4239223689 citedByCount "19" @default.
• W4239223689 countsByYear W42392236892012 @default.
• W4239223689 countsByYear W42392236892014 @default.
• W4239223689 countsByYear W42392236892015 @default.
• W4239223689 countsByYear W42392236892017 @default.
• W4239223689 countsByYear W42392236892018 @default.
• W4239223689 countsByYear W42392236892019 @default.
• W4239223689 countsByYear W42392236892020 @default.
• W4239223689 countsByYear W42392236892021 @default.
• W4239223689 countsByYear W42392236892022 @default.
• W4239223689 countsByYear W42392236892023 @default.
• W4239223689 crossrefType "journal-article" @default.
• W4239223689 hasAuthorship W4239223689A5002560235 @default.
• W4239223689 hasAuthorship W4239223689A5029049881 @default.
• W4239223689 hasAuthorship W4239223689A5077191679 @default.
• W4239223689 hasBestOaLocation W42392236892 @default.
• W4239223689 hasConcept C118552586 @default.
• W4239223689 hasConcept C126322002 @default.
• W4239223689 hasConcept C142724271 @default.
• W4239223689 hasConcept C170493617 @default.
• W4239223689 hasConcept C197934379 @default.
• W4239223689 hasConcept C204787440 @default.
• W4239223689 hasConcept C27081682 @default.
• W4239223689 hasConcept C2778375690 @default.
• W4239223689 hasConcept C2778541695 @default.
• W4239223689 hasConcept C2778871607 @default.
• W4239223689 hasConcept C2778938600 @default.
• W4239223689 hasConcept C2780580376 @default.
• W4239223689 hasConcept C2780852908 @default.
• W4239223689 hasConcept C2780966972 @default.
• W4239223689 hasConcept C42219234 @default.
• W4239223689 hasConcept C67774102 @default.
• W4239223689 hasConcept C71924100 @default.
• W4239223689 hasConcept C85663871 @default.
• W4239223689 hasConcept C98274493 @default.
• W4239223689 hasConceptScore W4239223689C118552586 @default.
• W4239223689 hasConceptScore W4239223689C126322002 @default.

• next